Tecogen price target lowered to $10 from $12 at Roth Capital

Roth Capital lowered the firm’s price target on Tecogen (TGEN) to $10 from $12 and keeps a Buy rating on the shares after its Q4 results. The firm continues to find Tecogen poised to benefit from a compelling opportunity in the data center cooling market which will drive accelerating revenue growth, the analyst tells investors in a research note. The timing of orders is inherently challenging, but Roth sees an attractive entry point and expects improving financial performance later this year, the firm noted.